Where Will Fluor Stock Be in 1 Year?

Fluor has shifted to a lower-risk contract mix, with more than 80% of backlog now reimbursable, and management expects that share to keep rising. Analysts see adjusted EPS growing 18% in 2026 and 28% in 2027, while the company recently generated an estimated $1.86B raw profit from liquidating its NuScale stake. The article argues the stock could rise about 28% over the next 12 months if it trades at 21x current-year earnings and growth materializes.

Analysis

The market is likely underappreciating how much FLR’s risk profile has changed now that reimbursable work dominates the backlog. That shift does more than smooth earnings: it lowers the probability of one-off misses that previously forced the multiple to stay capped, which matters because industrial contractors often re-rate on volatility reduction before growth acceleration shows up in reported numbers. The cleaner earnings stream should also make the stock more usable in factor portfolios, potentially attracting incremental institutional ownership over the next 2-3 quarters.

The bigger second-order winner may be the broader nuclear and AI infrastructure supply chain. FLR’s pivot suggests that hyperscale data center and advanced energy buildouts are becoming financeable at scale, which should support peers with similar project mixes and execution discipline, while pressuring contractors still reliant on fixed-price megaprojects. At the same time, the NuScale exit removes a binary overhang and converts a speculative embedded asset into visible liquidity, improving capital allocation optionality rather than just boosting headline earnings power.

The consensus seems to be treating FLR as a steady compounder, but the real upside is a de-risking multiple expansion plus 2026-27 EPS growth, not just the earnings ramp. The risk is timing: if reimbursable conversion slows or backlog growth stalls, the market could conclude that the quality upgrade is already in the price and compress the valuation back toward a low-teens contractor multiple. Any macro wobble in industrial capex or a delay in AI/nuclear project awards would likely hit the stock first through sentiment, then through estimate revisions over the next 1-2 reporting cycles.

Key Decisions for Investors

• Go long FLR on any pullback toward the low end of its recent trading range; target 6-9 month upside from multiple expansion as earnings volatility fades. Risk/reward favors owning the re-rating ahead of visible estimate revisions.
• Pair trade: long FLR / short a lower-quality fixed-price E&C peer with more lump-sum exposure. The spread should benefit over the next 2-3 quarters if project execution remains clean and investor preference shifts toward lower-risk backlog.
• If options liquidity permits, buy 6-12 month FLR call spreads rather than outright equity. This captures the thesis of modest multiple expansion plus EPS growth while limiting downside if the market already prices in the de-risking.
• Avoid or underweight SMR on the liquidation overhang; the monetization removes a strategic sponsor and leaves the stock more dependent on narrative than fundamentals. Use any strength in SMR to fade into the event window.
• Monitor FLR’s next two quarters for backlog mix and margin stability; if reimbursable mix stalls or management reintroduces lump-sum exposure, cut the position quickly, as the valuation thesis weakens faster than the earnings thesis.